Latest Underwriting News

Page 9 of 68
Gryphon Capital Income Trust has secured firm commitments for an $86.25 million wholesale placement, giving the fund fresh capital for incremental portfolio management. A further unit purchase plan of up to $30,000 per existing unitholder is also planned for the coming months.
Claire Turing
Claire Turing
8 Sept 2026
Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.
Ada Torres
Ada Torres
4 Sept 2026
Podium Minerals has secured the full $4 million from its underwritten share purchase plan after sub-underwriters covered a $2.44 million shortfall. The funds will support metallurgical testing, site rehabilitation, and project advancement at Parks Reef and Range Well.
Maxwell Dee
Maxwell Dee
4 Sept 2026
FireFly Metals has raised approximately A$180 million through a dual-market equity raising to accelerate development of its Green Bay Copper-Gold Project in Newfoundland, Canada.
Maxwell Dee
Maxwell Dee
4 Sept 2026
Titomic has raised A$16.5 million through an institutional placement priced at a 23.5% discount, aiming to scale its Huntsville facility and accelerate US growth. The company also advanced a US$10 million loan application with the Export-Import Bank and appointed aerospace veteran Jim Chilton to its board.
Victor Sage
Victor Sage
2 Sept 2026
Actinogen Medical has locked in full underwriting for nearly 127 million unlisted options, guaranteeing $4.77 million in fresh funding as it approaches pivotal Alzheimer’s trial results due in November.
Ada Torres
Ada Torres
1 Sept 2026
Podium Minerals' recent share purchase plan secured $1.56 million, significantly below its $4 million underwritten target, leaving a $2.44 million shortfall to be addressed.
Maxwell Dee
Maxwell Dee
1 Sept 2026
Pengana Global Private Credit Trust (ASX: PCX) reported a solid FY26 with an 8.8% cash distribution yield and stable credit quality despite fair value pressures from widening credit spreads.
Victor Sage
Victor Sage
31 Aug 2026
Alterity Therapeutics has arranged an underwriting deal for up to 8.4 million ATHO options, potentially raising A$4.2 million to A$7.96 million ahead of their expiry. The funds aim to support the upcoming Phase 3 trial for ATH434 in Multiple System Atrophy and bolster working capital.
Ada Torres
Ada Torres
31 Aug 2026
Babylon Pump & Power has successfully raised $7.27 million through an entitlement offer combining cash and debt conversion, strengthening its focus on water management rentals. Blue Hire founder Byron Ynema joins the board as the largest shareholder.
Victor Sage
Victor Sage
28 Aug 2026
HITIQ Limited posted a 21% drop in revenue to $1.59 million and reduced its net loss by 15% to $6.1 million for FY26, advancing commercialisation of its concussion management platform PROTEQT™ despite ongoing funding pressures and regulatory hurdles.
Ada Torres
Ada Torres
28 Aug 2026
NobleOak Life delivered robust FY26 results with in-force premiums climbing 18% to $549.2 million and underlying NPAT up 15%, driven by strong market share gains and operational efficiency.
Claire Turing
Claire Turing
28 Aug 2026

Browse the archive

Full archive